Steroid 21-hydroxylase deficiency is a major cause of congenital adrenal hyperplasia and is caused by genetic impairment of this enzyme. Since approximately 80% of cases are caused by point mutations of the CYP21B (CYP21A2) gene, whereas the remaining 20% are due to deletion of this gene, we used the polymerase chain reaction single strand conformation polymorphism technique for rapid and accurate diagnosis of this disease. Of 23 patients examined, 1 had a hemizygous CYP21B gene. 18 patient's genes localized their harmful mutations or deletion on both the alleles, while 4 of them found their causative mutations on one of the two alleles, and 1 failed to find any responsible mutation. All the mutations (four nucleotide substitutions) detected are also found in the CYP21A (CYP21A1) pseudogene. A mutation at the intron 2 site is most prevalent in both salt-wasting and simple virilizing forms of the disease, and accounts for 37% of the patient's genes (17/46). Pedigree analysis of these mutations revealed that the mutations (at least four of them) occurred de novo at a considerable frequency on both the paternally and maternally inherited chromosomes. This result could explain occasional discordance of the diagnosis using HLA typing with the clinical symptoms.
T Tajima, K Fujieda, K Nakayama, Y Fujii-Kuriyama
Title and authors | Publication | Year |
---|---|---|
Congenital Adrenal Hyperplasia and Human Leukocyte Antigen B: A Meta-Analysis.
Thibaut D, Walter MR, McGonegal C, Daniel R, Goodman J |
Cureus | 2023 |
Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision).
Ishii T, Kashimada K, Amano N, Takasawa K, Nakamura-Utsunomiya A, Yatsuga S, Mukai T, Ida S, Isobe M, Fukushi M, Satoh H, Yoshino K, Otsuki M, Katabami T, Tajima T |
2022 | |
The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
D Pignatelli, BL Carvalho, A Palmeiro, A Barros, SG Guerreiro, D Maçut |
Frontiers in Endocrinology | 2019 |
Analysis of phenotypes and genotypes in 84 patients with 21-Hydroxylase deficiency in southern China
L Hou, L Liang, S Lin, H Ou, Z Liu, S Huang, L Zhang, Z Meng |
Steroids | 2019 |
Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)
T Ishii, M Anzo, M Adachi, K Onigata, S Kusuda, K Nagasaki, S Harada, R Horikawa, M Minagawa, K Minamitani, H Mizuno, Y Yamakami, M Fukushi, T Tajima |
Clinical Pediatric Endocrinology | 2015 |
Clinical profile and inheritance pattern of CYP21A2 gene mutations in patients with classical congenital adrenal hyperplasia from 10 families
A Sharma, R Khadgawat, ML Khurana, AC Ammini, S Yadav, S Birla, E Marumudi |
Indian journal of endocrinology and metabolism | 2015 |
Prenatal diagnosis of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency
M Yau, C Pina, A Khattab, A Barhen, MI New |
Expert Opinion on Orphan Drugs | 2015 |
Genetic Steroid Disorders
DE Reichman, Z Rosenwaks |
Genetic Steroid Disorders | 2014 |
Results from 28 years of newborn screening for congenital adrenal hyperplasia in sapporo
S Morikawa, A Nakamura, K Fujikura, M Fukushi, T Hotsubo, J Miyata, K Ishizu, T Tajima |
Clinical Pediatric Endocrinology | 2014 |
Molecular Characterization of 25 Chinese Pedigrees with 21-Hydroxylase Deficiency
Y Yu, J Wang, X Huang, Y Wang, P Yang, J Li, SH Tsuei, Y Shen, Q Fu |
Genetic Testing and Molecular Biomarkers | 2011 |
High-resolution melting curve (HRM) analysis to establish CYP21A2 mutations converted from the CYP21A1P in congenital adrenal hyperplasia
YC Lin, YC Lin, TC Liu, JG Chang, HH Lee |
Clinica Chimica Acta | 2011 |
Oxidation of the Endogenous Cannabinoid Arachidonoyl Ethanolamide by the Cytochrome P450 Monooxygenases: Physiological and Pharmacological Implications
NT Snider, VJ Walker, PF Hollenberg |
Pharmacological reviews | 2010 |
Application of the DHPLC method for mutational detection of the CYP21A2 gene in congenital adrenal hyperplasia
LP Tsai, CF Cheng, JP Hsieh, M Teng, HH Lee |
Clinica Chimica Acta | 2009 |
A nagy géndeletiók kimutatásának módszerei és alkalmazásuk egyes örökletes betegségekben
P Gergics, J Tőke, Á Szilágyi, Á Szappanos, Z Kender, G Barta, M Tóth, P Igaz, K Rácz, A Patócs |
Orvosi Hetilap | 2009 |
A Bioinformatics Approach for the Phenotype Prediction of Nonsynonymous Single Nucleotide Polymorphisms in Human Cytochromes P450
LL Wang, Y Li, SF Zhou |
Drug Metabolism and Disposition | 2009 |
Prenatal Diagnosis and Treatment of Steroid 21-Hydroxylase Deficiency
T Tajima, K Fujieda |
Clinical Pediatric Endocrinology | 2008 |
Identification of Frequency and Distribution of the Nine Most Frequent Mutations among Patients with 21-Hydroxylase Deficiency in Turkey
F Sadeghi, N Yurur-Kutlay, M Berberoglu, E Cetinkaya, Z Aycan, C Kara, HI Ruhi, G Ocal, Z Şıklar, A Elhan, A Tukun |
Journal of Pediatric Endocrinology and Metabolism | 2008 |
HLA Typing of Patients with 21-Hydroxylase Deficiency in Iranian Children with Congenital Adrenal Hyperplasia
MT Ashtiani, A Rabbani, F Mostafavi, M Monajemzadeh, FR Kermani, J Soltaninia |
Biochemical Genetics | 2008 |
Prenatal Diagnosis and Treatment of Steroid 21-Hydroxylase Deficiency
T Tajima, K Fujieda |
Clinical Pediatric Endocrinology | 2008 |
Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
FG Riepe, WG Sippell |
Reviews in Endocrine and Metabolic Disorders | 2007 |
Nonclassic Steroid 21-Hydroxylase Deficiency due to a Homozygous V281L Mutation in CYP21A2 Detected by the Neonatal Mass-Screening Program in Japan
T SHINAGAWA, R HORIKAWA, T ISOJIMA, Y NAIKI, T TANAKA, N KATSUMATA |
Endocrine Journal | 2007 |
Diversity of theCYP21P-Like Gene inCYP21Deficiency
HH Lee |
DNA and Cell Biology | 2005 |
Molecular Analysis of the <i>CYP21</i> Gene and Prenatal Diagnosis in Families with 21-Hydroxylase Deficiency in Northeastern Iran
R Vakili, A Baradaran-Heravi, B Barid-Fatehi, M Gholamin, N Ghaemi, MR Abbaszadegan |
Hormone Research | 2005 |
The chimeric CYP21P/CYP21 gene and 21-hydroxylase deficiency
HH Lee |
Journal of Human Genetics | 2004 |
Mutation of IVS2 –12A/C>G in Combination with 707–714delGAGACTAC in the CYP21 Gene Is Caused by Deletion of the C4-CYP21 Repeat Module with Steroid 21-Hydroxylase Deficiency
HH Lee, SF Chang, FJ Tsai, LP Tsai, CY Lin |
The Journal of clinical endocrinology and metabolism | 2003 |
Bases Moleculares da Hiperplasia Adrenal Congênita
MP de Mello, TA Bachega, M Costa-Santos, LM Mermejo, M Castro |
Arquivos brasileiros de endocrinologia e metabologia | 2002 |
Multiplex Minisequencing of the 21-Hydroxylase Gene as a Rapid Strategy to Confirm Congenital Adrenal Hyperplasia
N Krone, A Braun, S Weinert, M Peter, AA Roscher, CJ Partsch, WG Sippell |
Clinical chemistry | 2002 |
Noninvasive Prenatal Exclusion of Congenital Adrenal Hyperplasia by Maternal Plasma Analysis: A Feasibility Study
RW Chiu, TK Lau, PT Cheung, ZQ Gong, TN Leung, YM Lo |
Clinical chemistry | 2002 |
CYP21 mutations and congenital adrenal hyperplasia
HH Lee |
Clinical Genetics | 2001 |
Novel mutations in the humanCYP21 gene
A Levo, J Partanen |
Prenatal Diagnosis | 2001 |
Molecular Diagnosis of CYP21 Mutations in Congenital Adrenal Hyperplasia
PW Speiser |
American Journal of PharmacoGenomics | 2001 |
CYP21 analysis and phenotype/genotype relationship in the screened population of the Italian Emilia-Romagna region
A Balsamo, E Cacciari, L Baldazzi, L Tartaglia, A Cassio, V Mantovani, S Piazzi, A Cicognani, P Pirazzoli, B Mainetti, F Zappulla |
Clinical Endocrinology | 2000 |
Rapid screening method to detect mutations inCYP21, the gene for 21-hydroxylase
Y Yokoyama, M Teraoka, K Tsuji, S Ninomiya, C Inoue, S Yamashita, K Narahara, Y Seino |
American Journal of Medical Genetics | 2000 |
Use of TaqI Digestion May Lead to Incorrect Molecular Diagnosis of Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
HH Lee, IJ de Wijs, EA Sistermans |
Molecular Genetics and Metabolism | 2000 |
Analysis of the chimeric CYP21P/CYP21 gene in steroid 21-hydroxylase deficiency
HH Lee, JG Chang, CH Tsai, FJ Tsai, HT Chao, B Chung |
Clinical chemistry | 2000 |
A False Negative Case with 21-Hydroxylase Deficiency at Newborn Mass Screenning Program. Case Report and Review of the Mass Screening Program in Kagoshima Prefecture
K Hizukuri, S Ono, R Masuda, M Mizota, K Otsubo, S Eto, I Tamada, S Fukami, K Fujieda |
Clinical Pediatric Endocrinology | 2000 |
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency*
PC White, PW Speiser |
Endocrine reviews | 2000 |
Mutation distribution and CYP21/C4 locus variability in Brazilian families with the classical form of the 21-hydroxylase deficiency
LC Paulino, M Araujo, G Guerra, SH Marini, MP Mello |
Acta Paediatrica | 1999 |
Steroid 21-hydroxylase deficiency: Mutational spectrum in Denmark, three novel mutations, and in vitro expression analysis
G Ohlsson, J M�ller, NE Skakkeb�k, M Schwartz |
Human Mutation | 1999 |
Congenital Adrenal Hyperplasia: Molecular Genetics and Alternative Approaches to Treatment
CA Stratakis, OM Rennert |
Critical Reviews in Clinical Laboratory Sciences | 1999 |
High frequency of a splice mutation in intron 2 of the 21-hydroxylase gene in Russia could be partly explained by a founder effect
AV Polyakov, IG Dzenis, VA Baharev, OV Evgrafov |
Human Mutation | 1998 |
Uniparental disomy for chromosome 6 results in steroid 21-hydroxylase deficiency: evidence of different genetic mechanisms involved in the production of the disease
AU Lopez-Gutierrez, L Riba, ML Ordonez-Sanchez, S Ramirez-Jimenez, M Cerrillo-Hinojosa, MT Tusie-Luna |
Journal of medical genetics | 1998 |
Salt-Wasting Congenital Adrenal Hyperplasia: Detection of Mutations in CYP21B Gene in a Chilean Population1
CE Fardella, H Poggi, P Pineda, J Soto, I Torrealba, AI Cattani, E Oestreicher, A Foradori |
The Journal of clinical endocrinology and metabolism | 1998 |
Characterisation of CAH alleles with non-radioactive DNA single strand conformation polymorphism analysis of the CYP21 gene
A Bobba, A Iolascon, S Giannattasio, M Albrizio, A Sinisi, F Prisco, F Schettini, E Marra |
Journal of medical genetics | 1997 |
Steroid 21-hydroxylase expression and activity in human lymphocytes
Z Zhou, VR Agarwal, N Dixit, P White, PW Speiser |
Molecular and Cellular Endocrinology | 1997 |
Rapid detection of 21-hydroxylase deficiency mutations by allele-specific in vitro amplification and capillary zone electrophoresis
P Carrera, AM Barbieri, M Ferrari, PG Righetti, M Perego, C Gelfi |
Clinical chemistry | 1997 |
Phenotypic evolution of classic 21-hydroxylase deficiency
WH Hoffman, MY Shln, PA Donohoue, SW Helman, SL Brown, G Rosculet, VB Mahesh |
Clinical Endocrinology | 1996 |
Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia
HH Lee, HT Chao, HT Ng, KB Choo |
Journal of medical genetics | 1996 |
Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency
B Barbat, A Bogyo, MC Raux-Demay, F Kuttenn, J Boué, B Simon-Bouy, JL Serre, A Boué, E Mornet |
Human Mutation | 1995 |
Splicing mutation inCYP21 associated with delayed presentation of salt-wasting congenital adrenal hyperplasia
B Kohn, D Day, R Alemzadeh, D Enerio, SV Patel, JV Pelczar, PW Speiser |
American Journal of Medical Genetics | 1995 |
Analysis of steroid 21-hydroxylase gene mutations in the Spanish population
B Ezquieta, A Oliver, R Gracia, PG Gancedo |
Human Genetics | 1995 |
Mutations in Steroid 21-Hydroxylase (CYP21)
PC White, MT Tusie-Luna, MI New, PW Speiser |
Human Mutation | 1994 |